Immunicum AB (publ) Announces End of Enrollment in Phase I/II GIST Clinical Trial

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Immunicum AB (publ) Announces End of Enrollment in Phase I/II GIST Clinical Trial
 8:00:25 AM

Keep reading
Immunicum AB (publ) Interim report January – March 2018Read